Overview of Safe Consumption Sites
Overview of safe drug consumption services - 1 page fact sheet draft
How do SCS impact public health? - 1 page fact sheet
How do SCS impact public safety and community? - 1 page fact sheet
The Case for Supervised Consumption Services - amFAR (June 2017)
research on Safe Consumption Sites
Addressing the nation’s opioid epidemic: lessons from an unsanctioned supervised injection site in the U.S.
Acceptability of safe consumption services among people who inject drugs
Establishing sanctioned safe consumption sites in the U.S.: Five jurisdictions moving the policy agenda forward
Impact of an unsanctioned safe consumption site on criminal activity, 2010 - 2019
Using drugs in un/safe spaces: Impact of perceived illegality on an underground supervised injecting facility in the U.S.
A cost-benefit analysis of a potential supervised injection facility in San Francisco
Evaluation of an unsanctioned safe consumption site in the U.S.
Overdose prevention site acceptability among residents and businesses surrounding a proposed site in Philadelphia
Reduced emergency department visits and hospitalization with use of an unsanctioned safe consumption site for injection drug use in the U.S.
gallery of safe consumption sites around the world
There are many models and options for safer drug consumption services (SCS). They are also referred to as drug consumption rooms (DCR), supervised injection facilities (SIF), and medically supervised injecting centers (MSIC). The European Monitoring Center for Drugs and Drug Addiction (EMCDDA) website offers extensive resources for evaluations of existing sites. The British Columbia Centre on Substance Use offers extensive research overviews for sites in Canada.